Jim Cramer highlighted Colgate-Palmolive (CL) as a consistent performer, even with modest growth, noting its recent positive quarter. Analysts from Morgan Stanley and Evercore ISI have raised price targets for CL, citing impressive organic sales growth and market share gains in key segments. The company’s stock has seen a 10.5% increase over the past year and 22% year-to-date.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Colgate (CL) Is Consistent, Says Jim Cramer
Jim Cramer highlighted Colgate-Palmolive (CL) as a consistent performer, even with modest growth, noting its recent positive quarter. Analysts from Morgan Stanley and Evercore ISI have raised price targets for CL, citing impressive organic sales growth and market share gains in key segments. The company’s stock has seen a 10.5% increase over the past year and 22% year-to-date.